JUPITER NEUROSCIENCES, INC. Earnings Per Share (Basic)
JUPITER NEUROSCIENCES, INC. (JUNS) reported Earnings Per Share (Basic) of -$4.08 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-14
- JUPITER NEUROSCIENCES, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$4.08.
- JUPITER NEUROSCIENCES, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.06.
- JUPITER NEUROSCIENCES, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.07.
- JUPITER NEUROSCIENCES, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.07.
- JUPITER NEUROSCIENCES, INC. earnings per share, basic for fiscal 2025 was -$0.25.
- JUPITER NEUROSCIENCES, INC. earnings per share, basic for fiscal 2024 was -$0.08.
- JUPITER NEUROSCIENCES, INC. earnings per share, basic for fiscal 2023 was -$0.18.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.08 10-Q · filed 2026-08-14 | -$8.44 10-Q · filed 2026-08-14 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||
| 2026-03-31 | -$0.06 10-Q · filed 2026-05-14 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.19 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||
| 2025-12-31 | -$0.07 derived: net income ÷ weighted average shares · filed 2026-04-01 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-04-01 | -$0.29 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.25 10-K · filed 2026-04-01 | ||
| 2025-09-30 | -$0.07 10-Q · filed 2025-11-14 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.18 10-Q · filed 2025-11-14 | -$0.31 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||
| 2025-06-30 | -$5.09 10-Q · filed 2026-08-14 | -$0.07 10-Q · filed 2025-08-19 | -$8.49 10-Q · filed 2026-08-14 | -$0.11 10-Q · filed 2025-08-19 | -$0.24 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-08-14 |
| 2025-03-31 | -$0.05 10-Q · filed 2026-05-14 | -$0.09 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-08-14 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-08-14 | ||
| 2024-12-31 | -$0.05 derived: net income ÷ weighted average shares · filed 2026-04-01 | -$0.07 derived: net income ÷ weighted average shares · filed 2026-04-01 | -$0.06 derived: net income ÷ weighted average shares · filed 2026-04-01 | -$0.08 10-K · filed 2026-04-01 | ||
| 2024-09-30 | -$0.02 10-Q · filed 2025-11-14 | -$0.01 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$0.03 10-Q · filed 2025-11-14 | -$0.05 derived: net income ÷ weighted average shares · filed 2025-11-14 | ||
| 2024-06-30 | $0.01 10-Q · filed 2025-08-19 | -$0.01 10-Q · filed 2025-08-19 | -$0.03 derived: net income ÷ weighted average shares · filed 2025-08-19 | -$0.09 derived: net income ÷ weighted average shares · filed 2025-08-19 | ||
| 2024-03-31 | -$0.02 10-Q · filed 2025-05-15 | -$0.04 derived: net income ÷ weighted average shares · filed 2025-08-19 | -$0.11 derived: net income ÷ weighted average shares · filed 2025-08-19 | |||
| 2023-12-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2025-03-28 | -$0.08 derived: net income ÷ weighted average shares · filed 2025-03-28 | -$0.18 10-K · filed 2025-03-28 | |||
| 2023-09-30 | -$0.07 10-Q · filed 2024-12-23 | -$0.16 10-Q · filed 2024-12-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |